Conditions: Major Depressive Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 412
Healthy volunteers: no

Brief summary:
To evaluate the efficacy and the safety of ASC-01 (aripiprazole/sertraline combination) compared to sertraline monotherapy in patients with major depressive disorders who have responded incompletely to sertraline monotherapy.

Detailed description:

Arms:
arm 1: The dose of 3-12mg/100mg(Aripiprazole/Sertraline Combination)will be orally administered once daily arm 2: The dose of 0mg/100mg (Placebo/Sertraline Combination ）will be orally administered once daily

Interventions: intervention 1: ASC-01 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: